HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Yoshinori Ito Selected Research

Neonatal herpes

12/2015Recurrent neonatal herpes simplex virus infection with central nervous system disease after completion of a 6-month course of suppressive therapy: Case report.
1/2004Comparison of real-time and nested PCR assays for detection of herpes simplex virus DNA.
7/2002Quantitation of viral load in neonatal herpes simplex virus infection and comparison between type 1 and type 2.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Yoshinori Ito Research Topics

Disease

125Breast Neoplasms (Breast Cancer)
10/2022 - 01/2003
121Neoplasms (Cancer)
10/2022 - 01/2002
33Infections
06/2022 - 01/2000
27Neoplasm Metastasis (Metastasis)
05/2021 - 12/2002
21Esophageal Neoplasms (Esophageal Cancer)
01/2022 - 01/2009
18Pancreatic Neoplasms (Pancreatic Cancer)
07/2021 - 01/2005
17Uterine Cervical Neoplasms (Cancer of the Cervix)
05/2022 - 02/2007
16Epstein-Barr Virus Infections
10/2021 - 03/2006
15Lymphoma (Lymphomas)
01/2018 - 01/2006
14Esophageal Squamous Cell Carcinoma
03/2022 - 06/2013
14Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
12/2018 - 10/2002
11Colorectal Neoplasms (Colorectal Cancer)
12/2017 - 11/2004
10Disease Progression
07/2021 - 07/2006
10Carcinoma (Carcinomatosis)
02/2021 - 12/2002
8Prostatic Neoplasms (Prostate Cancer)
05/2021 - 01/2004
8Rectal Neoplasms (Rectal Cancer)
04/2021 - 04/2003
8Squamous Cell Carcinoma (Epidermoid Carcinoma)
04/2020 - 10/2009
8Lung Neoplasms (Lung Cancer)
12/2009 - 12/2002
7Human Influenza (Influenza)
10/2013 - 09/2003
7Inflammation (Inflammations)
09/2013 - 07/2003
6Brain Diseases (Brain Disorder)
01/2022 - 09/2003
6Neutropenia
09/2021 - 03/2007
6Diarrhea
09/2021 - 02/2002
6Adenocarcinoma
09/2017 - 02/2010
6Cardiovascular Diseases (Cardiovascular Disease)
01/2013 - 07/2006
5Febrile Seizures (Febrile Seizure)
01/2022 - 02/2003
5Leukopenia
09/2021 - 08/2008
5Fatigue
01/2021 - 11/2011
5Triple Negative Breast Neoplasms
05/2020 - 10/2015
5Squamous Cell Carcinoma of Head and Neck
01/2017 - 11/2014
5Pain (Aches)
09/2016 - 04/2003
5Dyspnea (Shortness of Breath)
01/2016 - 07/2006
5Obesity
12/2009 - 07/2003
4Lymphatic Metastasis
01/2021 - 04/2015

Drug/Important Bio-Agent (IBA)

29Trastuzumab (Herceptin)FDA Link
10/2022 - 01/2003
23Hormones (Hormone)IBA
10/2022 - 03/2004
23Biomarkers (Surrogate Marker)IBA
03/2022 - 01/2002
20DNA (Deoxyribonucleic Acid)IBA
05/2022 - 02/2003
19Carotenoids (Carotene)IBA
01/2013 - 01/2000
17AnthracyclinesIBA
10/2022 - 03/2006
17Capecitabine (Xeloda)FDA Link
04/2021 - 02/2004
17Docetaxel (Taxotere)FDA Link
01/2021 - 01/2004
17Cisplatin (Platino)FDA LinkGeneric
02/2020 - 05/2005
16taxaneIBA
10/2022 - 03/2006
14ErbB Receptors (EGF Receptor)IBA
10/2022 - 08/2008
14Fluorouracil (Carac)FDA LinkGeneric
10/2020 - 01/2005
13Paclitaxel (Taxol)FDA LinkGeneric
05/2017 - 01/2004
12CytokinesIBA
08/2013 - 01/2003
11human ERBB2 proteinIBA
10/2022 - 01/2004
11Cyclophosphamide (Cytoxan)FDA LinkGeneric
10/2020 - 02/2004
10Proteins (Proteins, Gene)FDA Link
07/2021 - 01/2004
10Lapatinib (GW572016)FDA Link
08/2018 - 01/2007
9Estrogen ReceptorsIBA
05/2022 - 08/2008
9Tocopherols (Tocopherol)IBA
12/2011 - 07/2002
8eribulinFDA Link
12/2021 - 01/2016
8Pharmaceutical PreparationsIBA
01/2020 - 04/2008
8AntioxidantsIBA
12/2011 - 07/2002
8Vitamin A (Retinol)FDA LinkGeneric
07/2010 - 07/2002
8Insulin-Like Growth Factor I (IGF-1)IBA
06/2010 - 12/2002
7pertuzumabIBA
10/2022 - 10/2017
7Fulvestrant (Faslodex)FDA Link
05/2022 - 01/2015
7Phenobarbital (Luminal)FDA Link
01/2018 - 07/2012
7C-Reactive ProteinIBA
09/2013 - 07/2003
7Insulin-Like PeptidesIBA
06/2010 - 12/2002
7Insulin-Like Growth Factor Binding Protein 3IBA
06/2010 - 12/2002
6AntigensIBA
05/2022 - 08/2008
6Aromatase InhibitorsIBA
01/2017 - 02/2012
6TamoxifenFDA LinkGeneric
10/2015 - 12/2007
6LycopeneIBA
12/2011 - 07/2002
6Insulin-Like Growth Factor II (Somatomedin A)IBA
06/2010 - 12/2002
5Taxoids (Taxanes)IBA
10/2022 - 01/2009
5Ado-Trastuzumab EmtansineIBA
10/2022 - 05/2016
5Aspartate Aminotransferases (Aspartate Transaminase)IBA
11/2018 - 11/2011
5SteroidsIBA
10/2015 - 07/2006
5Vinorelbine (Navelbine)FDA LinkGeneric
01/2015 - 05/2008
5Methotrexate (Mexate)FDA LinkGeneric
01/2015 - 01/2006
5EnzymesIBA
11/2014 - 12/2002
5ORALIT (ORS)IBA
06/2010 - 01/2003
5beta Carotene (Betacarotene)FDA Link
04/2009 - 07/2002
5Peptides (Polypeptides)IBA
08/2008 - 12/2002
4MicroRNAs (MicroRNA)IBA
01/2022 - 09/2013
4GemcitabineFDA Link
02/2021 - 09/2006
4Epirubicin (Ellence)FDA LinkGeneric
10/2020 - 02/2004
4Doxorubicin (Adriamycin)FDA LinkGeneric
10/2020 - 02/2007

Therapy/Procedure

90Radiotherapy
05/2022 - 04/2002
82Drug Therapy (Chemotherapy)
07/2021 - 04/2003
78Therapeutics
05/2022 - 02/2002
40Chemoradiotherapy
01/2022 - 04/2003
17Neoadjuvant Therapy
12/2021 - 01/2007
15Brachytherapy
05/2022 - 10/2010
10Liver Transplantation
10/2021 - 02/2011
8Segmental Mastectomy (Lumpectomy)
05/2021 - 11/2011
7Esophagectomy
01/2022 - 12/2015
7Adjuvant Chemotherapy
01/2021 - 03/2006
7Combination Drug Therapy (Combination Chemotherapy)
04/2016 - 01/2004
6Transplantation
08/2018 - 07/2010
5Time-to-Treatment
05/2022 - 04/2009
5Aftercare (After-Treatment)
09/2017 - 10/2013
5Immunotherapy
08/2008 - 06/2004
4Induction Chemotherapy
02/2021 - 11/2016